Communication skills in HPV prevention: An audit among Italian healthcare workers

Vaccine

Volumn 28, Issue 34, 2010, Pages 5609-5613

  Tafuri, S ^a   Martinelli, D ^b   Vece, M M ^a   Quarto, M ^a   Germinario, C ^a   Prato, R ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Communication skills; HPV vaccine; Pap test; STDs

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; ATTITUDE; CLINICAL PRACTICE; COMMUNICATION SKILL; CONDYLOMA ACUMINATUM; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; IMMUNIZATION; INTERVIEW; ITALY; KNOWLEDGE; MEDICAL AUDIT; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; WART VIRUS; ADULT; AGED; ATTITUDE TO HEALTH; FEMALE; HEALTH CARE PERSONNEL; INTERPERSONAL COMMUNICATION; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; SEXUALLY TRANSMITTED DISEASES; YOUNG ADULT;

ADULT; AGED; COMMUNICATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; ITALY; MALE; MEDICAL AUDIT; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; QUESTIONNAIRES; SEXUALLY TRANSMITTED DISEASES; YOUNG ADULT;

EID: 77955053790     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.028     Document Type: Article

References (34)

1. Koutsky L.A., Harper D.M. Chapter 13: current findings from prophylactic HPV vaccine trials. Vaccine 2006, 24(Suppl. 3):S114-S121.
2. Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A., et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004, 364(November 13-19 (9447)):1757-1765.
3. Munoz N., Castellsague X., de Gonzalez A.B., Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006, 24(Suppl. 3):S1-S10.
4. United Kingdom Department of Health HPV Vaccine Recommended for NHS Immunization Programme 2007, United Kingdom Department of Health Web site, [published October 27, accessed August 15, 2008]. http://nds.coi.gov.uk/environment/fullDetail.asp%3FReleaseID=325799%26NewsAreaID=2.
5. Shefer A., Markowitz L., Deeks S., Tam T., Irwin K., Garland S.M., et al. Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia. Vaccine 2008, 26(August 19 (Suppl 10)):K68-K75.
6. Agenzia Italiana del Farmaco. Determinazione 28 febbraio 2007 129/2007. Regime di rimborsabilità e prezzo di vendita della specialità medicinale «Gardasil» (vaccino papillomavirus umano), autorizzata con procedura centralizzata europea dalla Commissione europea.
7. Agenzia Italiana del Farmaco. Determinazione 29 ottobre 2007 168/2007. Regime di rimborsabilità e prezzo di vendita della specialità medicinale «Cervarix» (vaccino papillomavirus umano), autorizzata con procedura centralizzata europea dalla Commissione europea.
8. Conferenza permanente per i rapporti tra lo Stato e le Regioni e le province autonome di Trento e Bolzano. Intesa ai sensi dell'articolo 8, comma 6, della legge 5 giugno 2003, n. 131, del 20 dicembre 2007 concernente " Strategie per la vaccinazione anti-HPV in Italia" .
9. Trends in sexual risk behaviors among high school students-United States, 1991-2001. MMWR Morb Mortal Wkly Rep 2002, 51(38):856-859.
10. Gust D.A., Strine T.W., Maurice E., Smith P., Yusuf H., Wilkinson M., et al. Underimmunization among children: effects of vaccine safety concerns on immunization status. Pediatrics 2004, 114(July (1)):e16-e22.
11. Smith P.J., Chu S.Y., Barker L.E. Children who have received no vaccines: who are they and where do they live?. Pediatrics 2004, 114(1):187-195.
12. Kahn J.A., Rosenthal S.L., Hamann T., Bernstein D.I. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS 2003, 14(5):300-306.
13. Davis K., Dickman E.D., Ferris D., Dias J.K. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 2004, 8(3):188-194.
14. Waller J., Marlow L.A., Wardle J. Mothers' attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study. Cancer Epidemiol Biomarkers Prev 2006, 15(7):1257-1261.
15. Zimet G.D. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health 2005, 37(6 Suppl.):S17-S23.
16. Dempsey A.F., Zimet G.D., Davis R.L., Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 2006, 117(5):1486-1493.
17. Zimet G.D. Understanding and overcoming barriera to human papillomavirus vaccine acceptance. Curr Opin Obstet Gynecol 2006, 18(February (Suppl. 1)):s23-s28.
18. Pitts M., Clarke T. Human papillomavirus infections and risks of cervical cancer: what do women know. Health Educ Res 2002, 17:706-714.
19. Olshen E., Woods E.R., Austin S.B., Luskin M., Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 2005, 37(September (3)):248-251.
20. Holcomb B., Bailey J.M., Crawford K., Ruffin M.T. Adults' knowledge and behaviors related to human papillomavirus infection. J Am Board Fam Pract 2004, 17(January-February (1)):26-31.
21. Petersen L.K., Nielsen J., Vaesel H., Bronsgaard P.H., Kolby P., Madsen K.G. Knowledge of human papilloma virus-associated disease among women in general practice. Ugeskr Laeger 2009, 171(March (14)):1173-1177.
22. Braun V., Gavey N. Exploring the possibility of sexual-behavioural primary prevention interventions for cervical cancer. Aust NZ J Public Health 1998, 22:353-359.
23. Waller W., McCaffery K., Wardle J. Beliefs about the risk factors for cervical cancer in a British population sample. Prev Med 2004, 38:745-753.
24. McCaffer y K.J., Forrest S., Waller J., Desai M., Szarewski A., Wardle J. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African Carribean and white British women in the UK. Br J Cancer 2003, 88:42-46.
25. Tjalma W.A.A., Van Damme P. Who should be vaccinated against human papillomavirus. Int J Cancer 2006, 16:1498-1499.
26. Tjalma W.A.A., Van Damme P. Is the public enough aware to accept a vaccination program against human papillomavirus?. Vaccine 2005, 23:3231.
27. Pearce C.F., Wolfe L.M., DePasquale S.E., Breen J.M. Physician knowledge and opinione about sexually transmitted infections and the human papillomavirus vaccine: a community based survey. Teen Med 2009, 102(March (3)). 33-35, 42.
28. Winer, Rachel, Hughes J.P., Feng Q., O'Reilly S., Kiviat N.B., et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006, 354(June):2645-2654.
29. Il vaccino per l'HPV (virus del papilloma umano) e la prevenzione del cancro del collo dell'utero. Note e raccomandazioni della Societaì Italiana di Ginecologia e Ostetricia.
30. Gruppo di Lavoro S.It.I sulle Vaccinazioni. Nuovi vaccini: evidenze scientifiche e raccomandazioni. EDIZIONE: Panorama della Sanità.
31. Bert G, Quadrino S. Il Counselling sistemico. Edizioni Change.
32. Franceschi S., De Vuyst H Human papillomavirus vaccines and anal carcinoma. Curr Opin HIV AIDS 2009, 4(January (1)):57-63.
33. Simatherai D., Bradshaw C.S., Fairley C.K., Bush M., Heley S., Chen M.Y. What men who have sex with men think about the human papillomavirus vaccine. Sex Transm Infect 2009, 85(April (2)):148-149.
34. WHO Weekly epidemiological record 10 April 2009, 84th year No. 15 2009, vol. 84. p. 117-132.